186 related articles for article (PubMed ID: 36613736)
1. Novel Arylpiperazine Derivatives of Salicylamide with α
Żmudzka E; Lustyk K; Siwek A; Wolak M; Gałuszka A; Jaśkowska J; Kołaczkowski M; Sapa J; Pytka K
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613736
[TBL] [Abstract][Full Text] [Related]
2. The Antiarrhythmic and Hypotensive Effects of S-61 and S-73, the Pyrrolidin-2-one Derivatives with α
Lustyk K; Sałaciak K; Siwek A; Sapa J; Zaręba P; Gałuszka A; Pytka K
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142287
[TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic, hypotensive and α1-adrenolytic properties of new 2-methoxyphenylpiperazine derivatives of xanthone.
Rapacz A; Pytka K; Sapa J; Kubacka M; Filipek B; Szkaradek N; Marona H
Eur J Pharmacol; 2014 Jul; 735():10-6. PubMed ID: 24751714
[TBL] [Abstract][Full Text] [Related]
4. Chemically Homogenous Compounds with Antagonistic Properties at All α1-Adrenoceptor Subtypes but not β1-Adrenoceptor Attenuate Adrenaline-Induced Arrhythmia in Rats.
Pytka K; Lustyk K; Żmudzka E; Kotańska M; Siwek A; Zygmunt M; Dziedziczak A; Śniecikowska J; Olczyk A; Gałuszka A; Śmieja J; Waszkielewicz AM; Marona H; Filipek B; Sapa J; Mogilski S
Front Pharmacol; 2016; 7():229. PubMed ID: 27536240
[TBL] [Abstract][Full Text] [Related]
5. The Antiarrhythmic Activity of Novel Pyrrolidin-2-one Derivative S-75 in Adrenaline-Induced Arrhythmia.
Lustyk K; Sałaciak K; Zaręba P; Siwek A; Sapa J; Pytka K
Pharmaceuticals (Basel); 2021 Oct; 14(11):. PubMed ID: 34832847
[TBL] [Abstract][Full Text] [Related]
6. HBK-10, A Compound with α
Lustyk K; Sałaciak K; Siwek A; Filipek B; Sapa J; Marona H; Żelaszczyk D; Pytka K
Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297368
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic and α-Adrenoceptor Antagonistic Properties of Novel Arylpiperazine Derivatives of Pyrrolidin-2-one.
Zaręba P; Dudek M; Lustyk K; Siwek A; Starowicz G; Bednarski M; Nowiński L; Zygmunt M; Sapa J; Malawska B; Kulig K
Arch Pharm (Weinheim); 2015 Dec; 348(12):861-7. PubMed ID: 26523954
[TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic properties of some 1,4-disubstituted piperazine derivatives with α1-adrenoceptor affinities.
Kubacka M; Mogilski S; Filipek B; Marona H
Eur J Pharmacol; 2013 Nov; 720(1-3):237-46. PubMed ID: 24161912
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological evaluation of pyrrolidin-2-one derivatives as antiarrhythmic, antihypertensive and alpha-adrenolytic agents.
Kulig K; Spieces C; Sapa J; Caspers C; Filipek B; Malawska B
Pharmacol Rep; 2010; 62(1):68-85. PubMed ID: 20360617
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular activity of the chiral xanthone derivatives.
Szkaradek N; Rapacz A; Pytka K; Filipek B; Żelaszczyk D; Szafrański P; Słoczyńska K; Marona H
Bioorg Med Chem; 2015 Oct; 23(20):6714-24. PubMed ID: 26386822
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and development of new 2-substituted 1-[3-(4-arylpiperazin-1-yl)propyl]-pyrrolidin-2-one derivatives with antiarrhythmic, hypotensive, and alpha-adrenolytic activity.
Malawska B; Kulig K; Gippert A; Filipek B; Sapa J; Maciag D
Farmaco; 2005 Oct; 60(10):793-803. PubMed ID: 16181628
[TBL] [Abstract][Full Text] [Related]
13. Antiarrhythmic properties of some aroxyethylamine derivatives with adrenolytic activity.
Maciag D; Bednarski M; Filipek B; Pociecha T; Szkaradek N; Marona H
Pharmazie; 2008 Jun; 63(6):480-4. PubMed ID: 18604994
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic profile and endothelial action of novel decahydroquinoline derivatives.
Kozlovski VI; Vdovichenko VP; Chlopicki S; Malchik SS; Praliyev KD; Zcilkibayev OT
Pol J Pharmacol; 2004; 56(6):767-74. PubMed ID: 15662089
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antiarrhythmic, and antihypertensive effects of novel 1-substituted pyrrolidin-2-one and pyrrolidine derivatives with adrenolytic activity.
Malawska B; Kulig K; Filipek B; Sapa J; Maciag D; Zygmunt M; Antkiewicz-Michaluk L
Eur J Med Chem; 2002 Mar; 37(3):183-95. PubMed ID: 11900863
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of some aroxyethylamine derivatives for hypotensive properties and their affinities for adrenergic receptors.
Maciag D; Filipek B; Czekaj T; Marona H; Nowak G
Pharmazie; 2003 Dec; 58(12):899-905. PubMed ID: 14703970
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and adrenolytic activity of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol and its enantiomers. Part 1.
Groszek G; Bednarski M; Dybała M; Filipek B
Eur J Med Chem; 2009 Feb; 44(2):809-17. PubMed ID: 18599160
[TBL] [Abstract][Full Text] [Related]
18. Search for new antiarrhythmic and hypotensive compounds. Synthesis, antiarrhythmic, antihypertensive, and alpha-adrenoceptor blocking activity of novel 1-[(2-hydroxy-3-amino)]-propylpyrrolidin-2-one derivatives.
Filipek B; Sapa J; Malawska B; Kulig K; Antkiewicz-Michaluk L
Arch Pharm (Weinheim); 1997 Jul; 330(7):225-31. PubMed ID: 9311302
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic activity of some xanthone derivatives with β1-adrenoceptor affinities in rats.
Rapacz A; Sapa J; Bednarski M; Filipek B; Szkaradek N; Marona H
Eur J Pharmacol; 2014 Sep; 738():14-21. PubMed ID: 24876055
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and preliminary evaluation of pharmacological properties of some piperazine derivatives of xanthone.
Szkaradek N; Rapacz A; Pytka K; Filipek B; Siwek A; Cegła M; Marona H
Bioorg Med Chem; 2013 Jan; 21(2):514-22. PubMed ID: 23245804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
